Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2003
04/09/2003EP0915875B1 Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
04/09/2003EP0912191B1 Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine
04/09/2003EP0906303B1 Ring-fused dihydropyranes, process for the preparation and use thereof
04/09/2003EP0904273B1 Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist
04/09/2003EP0904272B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
04/09/2003EP0902684B1 Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs
04/09/2003EP0892793B1 Substituted tetracyclic tetrahydrofuran derivatives
04/09/2003EP0881881B1 Antiparasitic composition for treating and protecting pets
04/09/2003EP0874808B1 Biphenyl hydroxamate inhibitors of matrix metalloproteinases
04/09/2003EP0873123B1 Inhibitors of protein isoprenyl transferases
04/09/2003EP0862440B1 Therapeutic use of hemoglobin in promoting wound healing
04/09/2003EP0850224B1 Radiation-activated cytotoxin therapy
04/09/2003EP0848612B1 Use of calendula glycosides for the treatment of psoriasis
04/09/2003EP0843663B1 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases
04/09/2003EP0842156B1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
04/09/2003EP0831726B1 Health food product
04/09/2003EP0827396B1 Production scale method of forming microparticles
04/09/2003EP0806894B1 Micellar nanoparticles
04/09/2003EP0793492B1 Use of sclareolide for treating disorders characterised by excessive cell proliferation
04/09/2003EP0778774B1 New use of prostaglandins
04/09/2003EP0771197B1 Use of heterocyclic compounds as dopamines-d 3- ligands
04/09/2003EP0768898B1 Cascade-polymer complexes and methods of producing the same
04/09/2003EP0758327B1 Pyranone compounds useful to treat retroviral infections
04/09/2003EP0756483B1 Use of bisphophonates for inhibiting bone resorption following implantation of orthopedic prosthesis
04/09/2003EP0739345B1 Cyclic polyamines
04/09/2003EP0724439B1 Use of 2-(2alkylphenylamino)oxazolines and -thiazolines for the manufacture of a medicament with alpha 2 adrenergic effect
04/09/2003EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties
04/09/2003EP0707483B1 use of cyanoacrylate adhesives for the manufacture of formulations to inhibit skin ulceration
04/09/2003EP0674623B1 Bicyclic fibrinogen antagonists
04/09/2003CN1409726A Type I cytokine receptor TCCR
04/09/2003CN1409724A 雌二醇轭合物和其用途 Estradiol conjugates and uses thereof
04/09/2003CN1409722A Antagonists of BMP and TGF beta signalling pathway
04/09/2003CN1409721A Treatment of viral infections using LEVOVIRIN
04/09/2003CN1409720A Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
04/09/2003CN1409716A New amino propylphosphinic acid
04/09/2003CN1409715A Cyclopenteneone derivatives
04/09/2003CN1409714A Pentacycle taxane compounds
04/09/2003CN1409712A Pyrrolo [2,3-d] pyrimidine compounds
04/09/2003CN1409711A Fused naphthalene dinitrogen compound useful as HIV reverse transcriptase inhibitors
04/09/2003CN1409709A Substituted bisindolylmaleimides for inhibition of cell proliferation
04/09/2003CN1409708A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor
04/09/2003CN1409704A Heterocycle derivatives and drugs
04/09/2003CN1409703A 4-aminopiperidine derivatives and their use as medicine
04/09/2003CN1409701A Crystalline form of (S)-2-ethoxy-3-[4-(2-{4-methane sulfonyloxy phenyl} ethoxy) phenyl] propanoic acid
04/09/2003CN1409635A Treatment of systemic lupus erythematosus with dehydroepiandrosterone
04/09/2003CN1409634A Pharmaceutical combinations and their use in treating gastrointestinal disorders
04/09/2003CN1409633A Combinations of(S)-2-(benzylamino-methyl)-2,3,8,9-tetrahydro-7H-1,4-dioxion[2,3-e]indol-8-one and neuroleptics
04/09/2003CN1409632A Use of retigabin for treating neuropathic pain
04/09/2003CN1409631A New formulation
04/09/2003CN1409630A Sustainable-release formulations for treating CNS-mediated disorders
04/09/2003CN1409629A Agents for promoting fattening of animals and method of promoting fattening
04/09/2003CN1409627A Novel apparatus and process for preparing crystalline particles
04/09/2003CN1409626A Catechol oximes and their use in cosmetic and dermatological preparations
04/09/2003CN1409605A Method for increasing pet activity
04/09/2003CN1408714A Novel oripavine derivative and its medical use
04/09/2003CN1408703A New phenyl ethyl amine compounds having beta 2-receptor excitation and its producing method
04/09/2003CN1408422A Chinese herbal medicine for curing periodontitis and gingivitis
04/09/2003CN1408421A Traditional Chinese herbal medicine for curing frostbite
04/09/2003CN1408414A External use medicine for curing piles
04/09/2003CN1408410A External use plaster for curing cervical spondylopathy
04/09/2003CN1408409A Hair restorer
04/09/2003CN1408397A Composition containing melatonin and galangal fruit traditional Chinese medicine
04/09/2003CN1408395A Paste for curing burn and scald and its preparing method
04/09/2003CN1408369A Bear gall eye drops for improving eyesight and its producing method
04/09/2003CN1408363A Equalizing nutrient effervescent tablet and its preparing method
04/09/2003CN1408362A Nasopharynx liquid
04/09/2003CN1408361A Quick-acting prickly-heat powder
04/09/2003CN1408360A Use of algin oligosaccharide in anti-senility and anti-dementia
04/09/2003CN1408359A Lima liquid for curing nasopharyngeal disease
04/09/2003CN1408358A Recipe component of zinc gluconate colloid nose spray
04/09/2003CN1408357A Powder medicine suitable for human and animal trauma
04/09/2003CN1408356A Composition of mifepristone semi-solid skeleton preparation
04/09/2003CN1408355A Medicinal composition and medicine kit containing estrin
04/09/2003CN1408354A Compound preparation containing rifampicin and isoniazid and its preparing method
04/09/2003CN1408353A Use of tanshin polyphenolic acid B in preparing tumor curing medicine
04/09/2003CN1408352A Formula of iron-compensating agent chewing tablet
04/09/2003CN1408351A Slow-release urea and its preparing method
04/09/2003CN1408350A Medicine for curing burn and scald and its preparing method
04/09/2003CN1408349A Foot-and-mouth disease gene engineering polypeptide vaccine and its preparing method
04/09/2003CN1408348A Anti-cancer medicine with elemene as raw material and its preparing method
04/09/2003CN1408347A High nurity elemene anti-cancer medicine and its preparing method
04/09/2003CN1408346A Elemene aerosol and its preparing method
04/09/2003CN1408345A B-elemene aerosol and its preparing method
04/09/2003CN1408342A Physical stable spraying gel composition
04/09/2003CN1408336A Complex room container preparation
04/09/2003CN1408244A Fodder additive for resisting silkworm microsporidian
04/09/2003CN1105116C Thienopyrimidine with PDE V-inhibiting effect
04/09/2003CN1105115C 1'-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]- spiro [isobenzofuran-1(3H),4'-piperidine)] hydrohalogenides
04/09/2003CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds
04/09/2003CN1105113C Fungicidal pyrimidinones
04/09/2003CN1105112C Benzothiophenecarboxamide derivatives and PGD2 antagonist comprising them
04/09/2003CN1105111C Pyrazine compounds
04/09/2003CN1105104C New manufacturing process
04/09/2003CN1105102C Amino-butenate compound and preparation method thereof
04/09/2003CN1105101C Beta-sultonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors
04/09/2003CN1105100C Compound with anti-inflammatory and immunosuppressive activities
04/09/2003CN1105098C Process for preparing NMDA antagonists
04/09/2003CN1104910C Production of analgesic synergy by co-administration of sub-analtesic doses of mu-opioid. agonist and kappa-2 opoiid agonist
04/09/2003CN1104909C Composition for prevention and treatment of HIV-1 infection comprising at least two different HIV-1 reverse transcriptase inhibitors
04/09/2003CN1104908C Improved vision through photodynamic therapy of eye
1 ... 5509 5510 5511 5512 5513 5514 5515 5516 5517 5518 5519 5520 5521 5522 5523 5524 5525 5526 5527 5528 5529 ... 7860